Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fungi and cancer
Aurelia Saftien, Jens Puschhof, Eran Elinav
Gut (2023) Vol. 72, Iss. 7, pp. 1410-1425
Open Access | Times Cited: 25

Showing 25 citing articles:

Intracellular bacteria in cancer—prospects and debates
Lena Schorr, Marius Mathies, Eran Elinav, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Engineered Microorganisms for Advancing Tumor Therapy
Jinxuan Jia, Xiaocheng Wang, Xiang Lin, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 6
Unveiling the intratumoral microbiota within cancer landscapes
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Fungi, immunosenescence and cancer
Bin Xu, Zan Luo, Xing Niu, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 67-82
Closed Access
The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
Ting Ding, Chang Liu, Zhengyu Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Candida albicans overgrowth impairs anti-PD-1 immunotherapy in oral tumor-bearing mice
Xu Wang, Xinming Zhang, WU Shuang-shuang, et al.
hLife (2025)
Open Access
Dysbiosis and extraintestinal cancers
Rui He, Ping-Qian Qi, Lin-Zhen Shu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Early-life gut mycobiome core species modulate metabolic health in mice
Mackenzie W. Gutierrez, Erik van Tilburg Bernardes, Ellen Ren, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Interplay between acetylation and ubiquitination of imitation switch chromatin remodeler Isw1 confers multidrug resistance in Cryptococcus neoformans
Meng Yang, Yue Ni, Zhuoran Li, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 5
Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development
Xiaoyue Liang, Chen Ding, Jiannan Wang, et al.
International Journal of Oral Science (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Candida albicans-myeloid cells-T lymphocytes axis in the tumor microenvironment of oral tumor-bearing mice
Xu Wang, Tiansong Xu, Shuangshuang Wu, et al.
Cancer Letters (2024) Vol. 588, pp. 216814-216814
Closed Access | Times Cited: 4
The evil companion of OSCC: Candida albicans
Zhixin Yang, Shiyu Zhang, Ning Ji, et al.
Oral Diseases (2023) Vol. 30, Iss. 4, pp. 1873-1886
Closed Access | Times Cited: 8
Microbes mediated immunogenic cell death in cancer immunotherapy
Jumin Huang, Fu‐Gang Duan, Chun Xie, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 128-142
Closed Access | Times Cited: 7
Gut mycobiome core species causally modulate metabolic health in mice
Marie‐Claire Arrieta
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
PWWP domain-containing protein Crf4-3 specifically modulates fungal azole susceptibility by regulating sterol C-14 demethylase ERG11
Ping Yu, Shuting Ye, Mi Zhou, et al.
mSphere (2024)
Open Access | Times Cited: 1
Mechanism-guided fine-tuned microbiome potentiates anti-tumor immunity in HCC
Tao Liu, Ya Guo, Yanxia Liao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Preface to Special Edition: Microbiome, Inflammation and Cancer
Benjamin H. Mullish, Gianluca Ianiro
Best Practice & Research Clinical Gastroenterology (2024), pp. 101952-101952
Closed Access
Bidirectional relationship between gastrointestinal cancer and depression: The key is in the microbiota-gut-brain axis
Bryan Adrián Priego-Parra, J.M. Remes-Troche
World Journal of Gastroenterology (2024) Vol. 30, Iss. 48, pp. 5104-5110
Closed Access
Cancer Management and Therapies Related to Microorganisms
Hira Gul, Nosheen Masood
(2024), pp. 265-280
Closed Access
Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms
Kristin Moskal, Nimisha Khurana, Luisa Siegert, et al.
International Journal of Cancer (2024)
Open Access
The role of intratumoral microorganisms in the progression and immunotherapeutic efficacy of head and neck cancer
Xuzhe Fang, Weihong Tong, Sheng Wu, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 349-360
Open Access
Race-dependent variability in the human tumor mycobiome
Dan Coster, Thomy Margalit, Ben Boursi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The temporal dynamics of the gut mycobiome and its association with cardiometabolic health in a nationwide cohort of 12,641 Chinese adults
Wanglong Gou, Huijun Wang, Chang Su, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 10, pp. 101775-101775
Open Access
Oncogenic processes: a neglected parameter in the evolutionary ecology of animals
Frédéric Thomas, Klara Asselin, Nick MacDonald, et al.
Comptes Rendus Biologies (2024) Vol. 347, Iss. G1, pp. 137-157
Open Access
Editorial: New insights into the role of mycobiome in diseases
Wenjuan Wu, Jun Ding, Xiaoqi Zheng, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access
Page 1

Scroll to top